Literature DB >> 12184543

Identifying patients with gastroesophageal reflux disease: validation of a practical screening tool.

Joshua J Ofman1, Michael Shaw, Kay Sadik, Amy Grogg, Kirsten Emery, Jay Lee, Eileen Reyes, Steven Fullerton.   

Abstract

A reliable, accurate noninvasive method for identifying patients with gastroesophageal reflux disease (GERD) in the primary care setting is needed. A population-based case-finding instrument may assist managed care organizations in identifying candidates for disease management or quality improvement programs. Our aim was to develop and validate a GERD case-finding instrument. A 12-item "GERD Screener" was developed based on literature review and expert opinion with questions about heartburn and regurgitation frequency and severity and medication use, as well demographics and exclusion criteria. Categorical and continuous scoring methods with and without medication use were developed a priori. Using a telephone interview in a medical group, we identified and enrolled 100 subjects with a history of GERD-like symptoms and 103 controls. Each subject completed the GERD Screener, a validated gastrointestinal symptom questionnaire, the Digestive Health Symptom Index (DHSI), and was evaluated independently by two gastroenterologists using a structured format. Agreement by the two physicians that symptoms were consistent with GERD and required an intervention was considered the gold standard. In all, 70 subjects were classified as having GERD and 106 as controls using the gold standard (K = 0.73; 95% CI, 0.63-0.82). The scoring method for the screening instrument using a continuous measure of GERD symptoms (frequency and severity) and weighted medication use resulted in an area under ROC of 0.89 (95% CI, 0.84-0.94). Using a cutoff of >9 points, this measure was 83% sensitive and 83% specific. Compared to the gold standard, the DHSI GERD subscale has an area under ROC of 0.89 (95% CI, 0.84-0.94). The GERD Screener was highly correlated with the DHSI GERD subscale, r = 0.78 (95% CI 0.72-0.83; P < 0.0001). In conclusion, the GERD Screener has demonstrated construct, convergent, and predictive validity. It is shorter than existing validated instruments, practical, and easily administered, which may reduce the response and administrative burden. This may serve as a valuable case-finding instrument in primary-care and managed-care organizations wishing to implement programs to improve the quality and efficiency of care.

Entities:  

Mesh:

Year:  2002        PMID: 12184543     DOI: 10.1023/a:1016421401519

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota.

Authors:  G R Locke; N J Talley; S L Fett; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  Prevalence of symptoms suggestive of gastro-oesophageal reflux disease in an adult population.

Authors:  J Isolauri; P Laippala
Journal:  Ann Med       Date:  1995-02       Impact factor: 4.709

3.  A new questionnaire for gastroesophageal reflux disease.

Authors:  G R Locke; N J Talley; A L Weaver; A R Zinsmeister
Journal:  Mayo Clin Proc       Date:  1994-06       Impact factor: 7.616

4.  Evidence-based disease management.

Authors:  G Ellrodt; D J Cook; J Lee; M Cho; D Hunt; S Weingarten
Journal:  JAMA       Date:  1997-11-26       Impact factor: 56.272

5.  Self-Directed Treatment of Intermittent Heartburn: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Evaluation of Antacid and Low Doses of an H(2)-Receptor Antagonist (Famotidine).

Authors:  Thomas J. Simon; Roger G. Berlin; Andrea H. Gardner; Laura A. Stauffer; A. Lawrence Gould; Albert J. Getson
Journal:  Am J Ther       Date:  1995-05       Impact factor: 2.688

6.  Screening for depression in pregnancy: characteristics of the Beck Depression Inventory.

Authors:  W L Holcomb; L S Stone; P J Lustman; J A Gavard; D J Mostello
Journal:  Obstet Gynecol       Date:  1996-12       Impact factor: 7.661

7.  24-hour pH monitoring in symptomatic patients without erosive esophagitis who did not respond to antireflux treatment.

Authors:  R Fass; C Mackel; R E Sampliner
Journal:  J Clin Gastroenterol       Date:  1994-09       Impact factor: 3.062

8.  Methodological aspects of evaluation of Quality of Life in upper gastrointestinal diseases.

Authors:  E Dimenäs
Journal:  Scand J Gastroenterol Suppl       Date:  1993

9.  Omeprazole as a diagnostic tool in gastroesophageal reflux disease.

Authors:  B E Schenk; E J Kuipers; E C Klinkenberg-Knol; H P Festen; E H Jansen; H A Tuynman; M Schrijver; L A Dieleman; S G Meuwissen
Journal:  Am J Gastroenterol       Date:  1997-11       Impact factor: 10.864

10.  Cost of acid peptic disorders in a managed-care organization.

Authors:  R Segal; W L Russell; R Ben-Joseph; B Mansheim
Journal:  Clin Ther       Date:  1996 Mar-Apr       Impact factor: 3.393

View more
  8 in total

Review 1.  Questionnaire based gastroesophageal reflux disease (GERD) assessment scales.

Authors:  V Pratap Mouli; Vineet Ahuja
Journal:  Indian J Gastroenterol       Date:  2011-07-23

2.  Population-based assessment of gastrointestinal symptoms and diseases: Cappadocia Cohort, Turkey.

Authors:  Orhan Sezgin; Hale Akpınar; Birol Özer; Murat Törüner; Kadir Bal; Serhat Bor
Journal:  Turk J Gastroenterol       Date:  2019-12       Impact factor: 1.852

3.  Evaluation of a gastrointestinal symptoms questionnaire.

Authors:  H J Bovenschen; M J R Janssen; M G H van Oijen; R J F Laheij; L G M van Rossum; J B M J Jansen
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

4.  Test-based exclusion diets in gastro-esophageal reflux disease patients: a randomized controlled pilot trial.

Authors:  Michele Caselli; Giovanni Zuliani; Francesca Cassol; Nadia Fusetti; Elena Zeni; Natalina Lo Cascio; Cecilia Soavi; Sergio Gullini
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

5.  Helicobacter pylori Eradication Therapy in Nonulcer Dyspepsia is Beneficial.

Authors:  Mohammed Q Khan
Journal:  Saudi J Gastroenterol       Date:  2008-04       Impact factor: 2.485

6.  Gastrointestinal complaints in shift-working and day-working nurses in Iran.

Authors:  Hamid Reza Saberi; Ali Reza Moravveji
Journal:  J Circadian Rhythms       Date:  2010-10-07

7.  The relationship between the prevalence of nighttime gastroesophageal reflux disease and disease severity.

Authors:  Bonnie B Dean; Daniel Aguilar; Lawrence F Johnson; Ronnie Fass; William C Orr; James E McGuigan; Brian Calimlim; Ning Yan; Diana Morgenstern; Robert W Dubois
Journal:  Dig Dis Sci       Date:  2009-08-20       Impact factor: 3.199

8.  Applying data mining techniques in the development of a diagnostics questionnaire for GERD.

Authors:  Noya Horowitz; Menachem Moshkowitz; Zamir Halpern; Moshe Leshno
Journal:  Dig Dis Sci       Date:  2007-04-10       Impact factor: 3.487

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.